Total Payments
$260,010
2024 Payments
$55,589
Companies
29
Transactions
368
Medicare Patients
1,592
Medicare Billing
$220,343
Payment Breakdown by Category
Other$200,850 (77.2%)
Travel$34,078 (13.1%)
Consulting$13,800 (5.3%)
Food & Beverage$11,011 (4.2%)
Education$269.94 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200,850 | 69 | 77.2% |
| Travel and Lodging | $34,078 | 65 | 13.1% |
| Consulting Fee | $13,800 | 5 | 5.3% |
| Food and Beverage | $11,011 | 223 | 4.2% |
| Education | $269.94 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Clovis Oncology, Inc. | $98,786 | 93 | $0 (2022) |
| GlaxoSmithKline, LLC. | $95,857 | 76 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $34,785 | 50 | $0 (2024) |
| TESARO, Inc. | $25,380 | 49 | $0 (2019) |
| Medical Device Business Services, Inc. | $1,481 | 8 | $0 (2024) |
| AbbVie Inc. | $539.64 | 7 | $0 (2021) |
| Myriad Genetic Laboratories, Inc. | $404.62 | 7 | $0 (2024) |
| Amgen Inc. | $353.04 | 12 | $0 (2019) |
| Merck Sharp & Dohme LLC | $316.13 | 12 | $0 (2024) |
| Kyowa Kirin, Inc. | $238.54 | 13 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $55,589 | 53 | GlaxoSmithKline, LLC. ($53,258) |
| 2023 | $7,723 | 17 | AstraZeneca Pharmaceuticals LP ($4,782) |
| 2022 | $25,942 | 21 | GlaxoSmithKline, LLC. ($15,468) |
| 2021 | $26,611 | 27 | GlaxoSmithKline, LLC. ($16,579) |
| 2020 | $15,093 | 12 | GlaxoSmithKline, LLC. ($8,117) |
| 2019 | $46,513 | 77 | Clovis Oncology, Inc. ($25,624) |
| 2018 | $53,185 | 97 | Clovis Oncology, Inc. ($46,635) |
| 2017 | $29,354 | 64 | Clovis Oncology, Inc. ($20,069) |
All Payment Transactions
368 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $124.11 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $85.28 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | In-kind items and services | $1,125.62 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | In-kind items and services | $249.32 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $79.16 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $120.31 | General |
| Category: SURGERY | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Oncology | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | In-kind items and services | $2,082.66 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $107.09 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $87.09 | General |
| 09/23/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $26.00 | General |
| 09/13/2024 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 09/13/2024 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $14.00 | General |
| 09/12/2024 | Medical Device Business Services, Inc. | — | Travel and Lodging | In-kind items and services | $529.55 | General |
| 09/12/2024 | Medical Device Business Services, Inc. | — | Travel and Lodging | In-kind items and services | $446.30 | General |
| 09/12/2024 | Medical Device Business Services, Inc. | — | Travel and Lodging | In-kind items and services | $238.36 | General |
| 09/12/2024 | Medical Device Business Services, Inc. | — | Food and Beverage | In-kind items and services | $133.51 | General |
| 09/03/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 08/30/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $123.48 | General |
| Category: Oncology | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | Cash or cash equivalent | $128.64 | General |
| Category: ONCOLOGY | ||||||
| 08/02/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 303 | 415 | $174,038 | $49,072 |
| 2022 | 5 | 268 | 371 | $114,840 | $33,447 |
| 2021 | 19 | 507 | 8,766 | $235,357 | $70,412 |
| 2020 | 18 | 514 | 15,249 | $228,335 | $67,412 |
Total Patients
1,592
Total Services
24,801
Medicare Billing
$220,343
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 28 | 28 | $63,140 | $19,790 | 31.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 122 | $30,500 | $8,321 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 142 | 178 | $31,150 | $8,151 | 26.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 59 | 59 | $24,780 | $7,845 | 31.7% |
| 38570 | Biopsy and removal of lymph nodes of abdominal cavity using an endoscope | Facility | 2023 | 13 | 13 | $16,705 | $2,601 | 15.6% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2023 | 15 | 15 | $7,763 | $2,363 | 30.4% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 13 | 13 | $29,315 | $9,383 | 32.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 112 | $28,000 | $8,046 | 28.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 144 | 179 | $31,025 | $7,847 | 25.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 47 | 47 | $19,740 | $6,105 | 30.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 20 | $6,760 | $2,066 | 30.6% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 28 | 28 | $63,140 | $19,973 | 31.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 115 | $26,700 | $9,468 | 35.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 56 | 56 | $22,789 | $8,395 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 139 | 167 | $24,620 | $7,701 | 31.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 28 | 47 | $13,452 | $5,649 | 42.0% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 18 | 41 | $11,070 | $4,498 | 40.6% |
| 38900 | Lymph node imaging during surgery | Facility | 2021 | 15 | 15 | $7,590 | $2,388 | 31.5% |
| 38570 | Removal of abdominal cavity lymph nodes using an endoscope | Facility | 2021 | 11 | 11 | $14,135 | $2,246 | 15.9% |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | Office | 2021 | 15 | 41 | $5,535 | $2,220 | 40.1% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 18 | 152 | $12,920 | $2,010 | 15.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 14 | 66 | $5,280 | $1,994 | 37.8% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2021 | 18 | 401 | $10,025 | $947.23 | 9.4% |
| J9267 | Injection, paclitaxel, 1 mg | Office | 2021 | 12 | 6,424 | $3,212 | $878.14 | 27.3% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 12 | 35 | $2,100 | $850.35 | 40.5% |
About Dr. Wiley Bunn, MD
Dr. Wiley Bunn, MD is a Gynecologic Oncology healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902982473.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wiley Bunn, MD has received a total of $260,010 in payments from pharmaceutical and medical device companies, with $55,589 received in 2024. These payments were reported across 368 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($200,850).
As a Medicare-enrolled provider, Bunn has provided services to 1,592 Medicare beneficiaries, totaling 24,801 services with total Medicare billing of $220,343. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Location Syracuse, NY
- Active Since 10/27/2006
- Last Updated 01/17/2020
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1902982473
Products in Payments
- Rubraca (Drug) $98,679
- ZEJULA (Drug) $74,655
- JEMPERLI (Biological) $46,582
- LYNPARZA (Drug) $34,763
- SANCUSO (Drug) $238.54
- Tivdak (Drug) $234.79
- Elahere (Biological) $225.67
- OviTex 2S (Device) $210.00
- MYRISK (Device) $180.25
- Orilissa (Drug) $170.74
- Lupron (Drug) $169.84
- INJECTAFER (Drug) $156.11
- Neulasta (Biological) $149.66
- Da Vinci Surgical System (Device) $131.94
- myChoice CDx (Device) $130.84
- KEYTRUDA (Biological) $124.23
- Lenvima (Drug) $104.69
- SOLOSEC (Drug) $101.88
- Osphena (Drug) $97.50
- ORIAHNN (Drug) $93.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.